News

National Drug Observatories (NDOs) from Latin American and Caribbean (LAC) countries are gathering in Lisbon from 22–26 May for a week of activities under the COPOLAD III programme. The overarching theme of...

Representatives from a record 80 countries will be joining members of the EMCDDA this week (22–26 May) for the agency’s eleventh Reitox week . The purpose of this annual event is to...

How many new drugs were detected in Europe over the last year? What are the latest trends in drug production and trafficking? What substances are causing the most concern today? Find out...

I was very pleased to learn that the World Health Organization ( WHO ) declared this month that COVID-19 no longer constitutes a global health emergency. This is positive news for all...

Today, the EMCDDA and the General-Directorate for Intervention on Addictive Behaviours and Dependencies ( SICAD ) signed a Memorandum of Understanding (MoU) , formalising their cooperation in the organisation of the European...

Increasing knowledge on early-warning systems and complementary data-collection methods will be among the aims of a training event being held this week in Santiago de Chile (25–27 April 2023). Taking place under...

Analysing potential futures to support decision-making today is an approach increasingly used in a world characterised by rapid, volatile and complex change. More and more organisations, including EU bodies, are integrating foresight...

Strategic partnerships and international cooperation perspectives will be the focus of an EMCDDA stakeholder event taking place in Brussels today, ahead of the agency’s new mandate in 2024. The agency’s cooperation with...

A closely monitored substance by the name of hexahydrocannabinol (HHC) is the focus of a new EMCDDA report out today. Synthesised from cannabidiol (CBD) extracted from low-THC cannabis plants (hemp), it is...

The EMCDDA would like to offer its warmest congratulations to former colleague Julián Vicente who has been awarded with the Spanish Cruz Blanca de la Orden al Mérito del Plan Nacional sobre...

Analysing potential futures to support decision-making today is an approach increasingly used in a world characterised by rapid, volatile and complex change. More and more organisations, including EU bodies, are now integrating...

The latest findings from the largest European project in the science of wastewater analysis are released today in Wastewater analysis and drugs — a European multi-city study , published by the Europe-wide...

(20.03.2023) EMCDDA Director Alexis Goosdeel starts an official three-day visit to Austria today where he will meet with high-level officials including the Minister of Health, Johannes Rauch, and Minister of Justice, Dr...

An EMCDDA delegation is attending the sixty-sixth session of the Commission on Narcotic Drugs (CND) in Vienna this week (13-17 March), where it is providing technical support to the European Commission and...

Women make up approximately a quarter of all people with serious drug problems in Europe and around one-fifth of all entrants to drug treatment. Yet much still needs to be done to...

The EMCDDA Scientific Committee , meeting in Lisbon this week, re-elected its Chair and Vice Chair and welcomed four new members. Chair Prof. Dr. Catherine Comiskey (Ireland) and Vice-Chair Prof. Dr. Henri...

Bursaries for the 2023 European Drugs Summer School (EDSS) are currently being offered through the EMCDDA’s Instrument for Pre-accession Assistance 8 ( IPA8 ) project. Professionals, academics or experts from the Western...

Two bursaries for the 2023 European Drugs Summer School (EDSS) are currently being offered through EMCDDA’s EU4Monitoring Drugs II ( EU4MD II ) project. Professionals, academics or experts from the European Neighbourhood...

Message from the Director 1/2023 I am delighted to announce today the publication of the latest EMCDDA work programme , which outlines our activities for 2023–2025 ( 1 ). This period promises...

Two bursaries covering the registration fee for the 2023 European Drugs Summer School (EDSS) are currently being offered through the EMCDDA’s partnership with the COPOLAD III programme. Professionals, academics or experts from...